ResIn podcast now online!

ResIn project lead, Dr Michael Head, has recorded a podcast with the Public Policy@Southampton group. The second episode of their ‘Policy Pod’ series, Michael discusses with them the evolution of the ResIn study and how to influence and engage with policymakers.

Fancy a listen?! Click here to hear the Policy Pod. Follow Public Policy@Southampton on Twitter at @PublicPolicyUoS.




Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

Global funding analysis of R&D investments for pneumonia!

We are delighted to publish new findings from the Research Investments in Global Health study, hosted by the University of Southampton and funded by the Bill & Melinda Gates Foundation. The report, entitled ‘Sizing up pneumonia research’ summarises public and philanthropic investment for pneumonia-related research by the G20 countries between 2000 and 2015. It provides analysis of investment trends over time, the geography of pneumonia research funding, and levels of investment in specific priority areas such as paediatric, antimicrobial resistance and vaccine-focused research.

Overall, $3 billion of pneumonia-related research investment is described here, covering over 2000 studies from dozens of different funders. Despite the very high mortality (almost 1 million deaths per year, mostly in children aged under 5 in resource-poor settings), the volume of research into pneumonia is low, and the ‘Big Three’ of HIV, malaria and tuberculosis all receive greater levels of funding compared to their respective burden of disease. Pneumonia has been historically neglected by the global health community, and it’s time for that to change. Our analyses inform the evidence base around resource allocation and provide a platform for further multi-disciplinary stakeholder discussions including policymakers, funders, researchers and clinicians.

See for the full report.

Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

An afternoon of global health with ResIn and RSTMH

Free event – An afternoon of global health with ResIn and RSTMH
Monday 18 September, 3:15pm – 4:45pm
University of Southampton, Highfield Campus
All welcome!

Click here to register

Preceded by a brief introduction from Professor David Wilson, Associate Dean for Internationalisation, this event will include two talks –

a) Royal Society of Tropical Medicine and Hygiene Strategy Launch – RSTMH Chief Executive, Tamar Ghosh, will present the Society’s new strategy, including information about several new activities including mentoring, education and training. There will also be time to discuss the benefits of RSTMH membership which include journal access, a calendar of scientific and social events, plus a well-established grants round.

b) Presentation of the results of the Southampton-led Research Investments in Global Health Study (ResIn).
Funded by the Bill & Melinda Gates Foundation and enthusiastically received by (among others) the World Health Organisation, Dr’s Michael Head and Rebecca Brown have analysed 16 years of data on global infectious disease funding. How much funding goes to HIV research compared to tuberculosis? Is pneumonia an under-funded and neglected area? What does the research landscape look like for malaria investments in sub-Saharan Africa? What can we learn from the historical financing of research for Ebola? What should the research landscape look like going forward, and how should we in the global health community be setting future priorities?

This event is open to colleagues both within the University of Southampton and externally. Everybody is welcome!

Location – Senate Room, 4th floor, building 37, Highfield campus of the University of Southampton.

Webpage to register –

Click here for a pdf flyer of the event. 

Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

ResIn original research in Lancet Global Health – malaria investments in Africa

The latest analysis from the Research Investments in Global Health study has been published in The Lancet Global Health. This work covered malaria investments for R&D and funding for malaria control, and focused on their geographical distribution around sub-Saharan Africa.

Our research showed that countries that receive higher levels of funding for malaria-related research also typically receive higher levels of funding for malaria control (non-research investments). Thus, nations such as Kenya, Tanzania and Uganda are relatively well-funded compared to nations such as Chad, Central African Republic and Sierra Leone. We discuss some of the likely reasons for this and consider further analyses that underpin these findings, and add pragmatic commentary on potential ways forward.

The paper is open-access and available here. Suggested citation –

Head MG, Goss S, Gelister Y et al. Inequalities in investments: a systematic analysis of global funding trends for malaria research in sub-Saharan AfricaThe Lancet Global Health. 2017. doi: 10.1016/S2214-109X(17)30245-0

Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

First full ResIn article on cancer research investments

We are pleased to announce the first ResIn publication covering UK cancer research investments. It is published in BMJ Open, and the full open-access publication can be found by clicking here.

We assessed thousands of research projects covering all types of cancer, and identify areas of research strength in the UK and areas where the portfolio is relatively weak. Breast and prostate cancers, for example, received relatively high investment compared to burden of disease whilst there was little funding for cancer of the liver, thyroid, lung, upper GI tract and bladder, despite high burdens of disease. Around two-thirds of the investment is for pre-clinical science.


Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

New ResIn publication – R&D funding for Ebola

As part of the Research Investments in Global Health study (ResIn,, you may be interested in this our recent paper, led by colleague Joseph Fitchett and with Rifat Atun as senior author – we described funding for ebola R&D in the years prior to the 2014 outbreak and the responsive funding during the first year of the outbreak, covering $1 billion of investments from US and UK government, Wellcome, Gates etc. We’ve charted the funder, destination of those funds, and what they’re for (e.g. vaccine, diagnostics, therapeutics).

Now published ‘online first’ at Journal of Global Health

Paper is here –

PDF is here –

Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

ResIn meetings report published in BMC Proceedings

We are pleased to announce the publication of our meetings report in the open-access BMC Proceedings. This report covers three workshops held at the Wellcome Trust (London), UK Research Offices (Brussels) and the World Health Organisation (Geneva), set up to discuss the methods and results to date of the Research Investments in Global Health (ResIn) study, and to consider best ways forward for the project. Over 50 individuals attended from some of the world’s leading funders, policymakers, academic institutions and professional groups.

See the BMC Proceedings website for the report.

Suggested citation –
Head MG, Brown RJ. The activity of the Research Investments in Global Health study and ways forward within the global funding and policy landscape. BMC Proceedings. 2016. 10(Suppl 8):59. doi: 10.1186/s12919-016-0065-2



Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

Assessing funding for AMR research in South Korea

The Research Investments in Global Health (ResIn) study were delighted to collaborate with public health researchers in South Korea (Republic of Korea) on an analysis of R&D funding related to antimicrobial resistance (AMR).

Our original article has been published in the Journal of Global Antimicrobial Resistance. We assessed 198 project reports that had a total funding of US$18.3 million. Much of the funding (61.5%) was for implementation and operational research, and universities were the lead institutions for 73.2% of the awards. There was little funding for projects that had a focus on global health, and few projects had a focus on specific pathogens.

Suggested citation –  Ryu SH, Head MG, Kim BI, Hwang JC, Cho EH. Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Korea, 2003-2013. Journal of Global Antimicrobial Resistance. 2016. doi:10.1016/j.jgar.2016.03.007


Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

ResIn is offering bursaries for two summer students in 2016!

The Research Investments in Global Health study (ResIn) is delighted to have won a small grant from the Royal Society for Tropical Medicine and Hygiene! This will allow us to host two students this summer on paid bursaries at the University of Southampton, to pilot methods that combine research investment analyses with geospatial techniques. These placements would suit medical, MSc/Bsc, nursing students etc (all scientific disciplines considered, recent graduates or more experienced colleagues between posts will also be considered). For the geospatial activity, experience in GIS, geography and/or associated disciplines will be required.

More information…

We have available two (non-laboratory) research placements at the university this summer, one based at Southampton General Hospital in the Faculty of Medicine, and one (most likely) located at the university Highfield campus. The bursaries will each be £1600 for 10 weeks (pro-rata payment for shorter placement will be considered). Timing is flexible across July to October.

Project title – Combining research investments analyses and malaria maps in Africa – are we investing limited resources wisely? Part of the Research Investments in Global Health study, ResIn,

People involved – Michael Head (project lead, main supervisor), Stuart Clarke, Becky Brown (Faculty of Medicine, Southampton), Andy Tatem (Geography, Southampton), Joseph Fitchett (Harvard)

Background – The study is analysing global trends in funding for infectious disease research. We are currently collating research funding data from all the nations in the G20 and analysing the individual awards for relevance to infection, and then categorising them under diseases and disease areas, pathogens and type of science. In 12-18 months’ time we will have finalised a large global dataset of funding trends over the last 15 years and be able to identify areas of national and international research strength, areas of funding neglect, and be able to inform the R&D agenda of how to distribute limited financial resources as equitably as possible.

See  for our latest paper on mapping the UK funding landscape, and for the rest of our publications to give an idea of the sort of work we produce.

Placement activity of student handling the research funding data –  Here, we are going to focus on research investment data from the world’s leading global health funders. Some of this is already extracted and categorised, some of which the research funding student will need to collate and categorise (full supervision and support provided here, of course). As well as disease categories, they will need to pick out the awards with a geographical focus in sub-Saharan Africa e.g. ‘malaria vaccines trial in Kenya’. They will need to find out as precisely as possible where that research was taking place (reading study abstract, googling, institutional websites, reading published outputs related to the study etc), so it can be mapped by the geography student. There will be plenty of playing around in spreadsheets, with excel equations and manual sifting, analysis within Stata, and generating results via tables and visualisations, in order to generate some results about the extent and nature of the selected studies.

The geography/geospatial student – Having received a dataset of selected studies related to malaria that have a specified geographical focus, they will then integrate this information with existing datasets. The Malaria Atlas Project,, has mapped malaria burden to every grid square in sub-Saharan Africa.  The WorldPop data is also openly available, Using GIS/other methods, the student will produce some visualisations describing the location of where the research funding is targeted – what are the burdens, demographics and geography of these areas? This can help to answer questions such as – Are investments biased towards high transmission, sparsely populated rural areas, or high-density elimination settings? Are there geographic regions that have been neglected but could greatly benefit from being the focus of investment? Are we investing as equitably and ethically as possible?

Placement outputs
– written data and visuals;
– at least one peer-reviewed publication (on which both students would be authors);
– there is a small budget for conference attendance to present the results;
– also plans to host a meeting in London (probably at the Wellcome Trust) at the end of the project to highlight the study and results to influential funders and policymakers with an interest in this area, this is a good chance to build useful links, travel to and from London would be paid for.

Skills required – for the research investments student – a systematic approach to working with plenty of attention to detail, experience handling data in excel and any other stats/epidemiological software would be useful but not essential, interests in global health and infectious diseases (malaria in particular)
– for the geography/geospatial student – knowledge of GIS, experience with geospatial techniques, interests in global health and infectious diseases (malaria in particular)

If interested – send your CV and brief email of your background/interests in these areas to Michael Head at the University of Southampton, . Please state which of the two placements you are interested in. Deadline for expressions of interest – 31 May 2016.




Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook